Yuyu Pharma Achieves Double-Digit Growth in Q1 Results... Operating Profit Up 53%
Sales of 27.1 Billion Won and Operating Profit of 4.9 Billion Won on a Standalone Basis
Profitability Improved Through Production Efficiency... Expansion of Companion Animal Business Underway
Yuyu Pharma announced on May 15 that, on a standalone basis, it recorded sales of 27.1 billion won, operating profit of 4.9 billion won, and net profit of 3.9 billion won in the first quarter of this year.
Compared to the same period last year, sales increased by 19.4%, operating profit by 53.5%, and net profit by 59.2%, respectively.
The company stated that it is improving profitability by streamlining its production processes, while also expanding its companion animal business, which it is fostering as a new growth engine.
The shareholder return policy will also continue. Yuyu Pharma explained that it plans to complete the cancellation of its treasury shares within the first half of the year and promote an increase in dividends, aiming for separate taxation on high dividends.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Park Noyong, CEO of Yuyu Pharma, said, "We will continue to achieve profitable management this year by improving the operating margin through production process efficiency and ensuring the stable establishment of our companion animal business."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.